214 related articles for article (PubMed ID: 32661245)
1. High-performance CRISPR-Cas12a genome editing for combinatorial genetic screening.
Gier RA; Budinich KA; Evitt NH; Cao Z; Freilich ES; Chen Q; Qi J; Lan Y; Kohli RM; Shi J
Nat Commun; 2020 Jul; 11(1):3455. PubMed ID: 32661245
[TBL] [Abstract][Full Text] [Related]
2. Improving the efficiency of CRISPR-Cas12a-based genome editing with site-specific covalent Cas12a-crRNA conjugates.
Ling X; Chang L; Chen H; Gao X; Yin J; Zuo Y; Huang Y; Zhang B; Hu J; Liu T
Mol Cell; 2021 Nov; 81(22):4747-4756.e7. PubMed ID: 34648747
[TBL] [Abstract][Full Text] [Related]
3. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a.
Shin HR; Kweon J; Kim Y
Methods Mol Biol; 2021; 2162():185-193. PubMed ID: 32926383
[TBL] [Abstract][Full Text] [Related]
4. Expanding the scope of plant genome engineering with Cas12a orthologs and highly multiplexable editing systems.
Zhang Y; Ren Q; Tang X; Liu S; Malzahn AA; Zhou J; Wang J; Yin D; Pan C; Yuan M; Huang L; Yang H; Zhao Y; Fang Q; Zheng X; Tian L; Cheng Y; Le Y; McCoy B; Franklin L; Selengut JD; Mount SM; Que Q; Zhang Y; Qi Y
Nat Commun; 2021 Mar; 12(1):1944. PubMed ID: 33782402
[TBL] [Abstract][Full Text] [Related]
5. Harnessing noncanonical crRNA for highly efficient genome editing.
Xun G; Zhu Z; Singh N; Lu J; Jain PK; Zhao H
Nat Commun; 2024 May; 15(1):3823. PubMed ID: 38714643
[TBL] [Abstract][Full Text] [Related]
6. Multiplexed conditional genome editing with Cas12a in
Port F; Starostecka M; Boutros M
Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22890-22899. PubMed ID: 32843348
[TBL] [Abstract][Full Text] [Related]
7. Combined genome editing and transcriptional repression for metabolic pathway engineering in Corynebacterium glutamicum using a catalytically active Cas12a.
Liu W; Tang D; Wang H; Lian J; Huang L; Xu Z
Appl Microbiol Biotechnol; 2019 Nov; 103(21-22):8911-8922. PubMed ID: 31583448
[TBL] [Abstract][Full Text] [Related]
8. A Survey of Genome Editing Activity for 16 Cas12a Orthologs.
Zetsche B; Abudayyeh OO; Gootenberg JS; Scott DA; Zhang F
Keio J Med; 2020 Sep; 69(3):59-65. PubMed ID: 31723075
[TBL] [Abstract][Full Text] [Related]
9. Optimization of AsCas12a for combinatorial genetic screens in human cells.
DeWeirdt PC; Sanson KR; Sangree AK; Hegde M; Hanna RE; Feeley MN; Griffith AL; Teng T; Borys SM; Strand C; Joung JK; Kleinstiver BP; Pan X; Huang A; Doench JG
Nat Biotechnol; 2021 Jan; 39(1):94-104. PubMed ID: 32661438
[TBL] [Abstract][Full Text] [Related]
10. Gene editing with CRISPR-Cas12a guides possessing ribose-modified pseudoknot handles.
Ageely EA; Chilamkurthy R; Jana S; Abdullahu L; O'Reilly D; Jensik PJ; Damha MJ; Gagnon KT
Nat Commun; 2021 Nov; 12(1):6591. PubMed ID: 34782635
[TBL] [Abstract][Full Text] [Related]
11. Good guide, bad guide: spacer sequence-dependent cleavage efficiency of Cas12a.
Creutzburg SCA; Wu WY; Mohanraju P; Swartjes T; Alkan F; Gorodkin J; Staals RHJ; van der Oost J
Nucleic Acids Res; 2020 Apr; 48(6):3228-3243. PubMed ID: 31989168
[TBL] [Abstract][Full Text] [Related]
12. Design and Evaluation of Guide RNA Transcripts with a 3'-Terminal HDV Ribozyme to Enhance CRISPR-Based Gene Inactivation.
Berkhout B; Gao Z; Herrera-Carrillo E
Methods Mol Biol; 2021; 2167():205-224. PubMed ID: 32712922
[TBL] [Abstract][Full Text] [Related]
13. Multiplexed Genome Engineering with Cas12a.
Weisbach NR; Meijs A; Platt RJ
Methods Mol Biol; 2021; 2312():171-192. PubMed ID: 34228291
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of target specificity of CRISPR-Cas12a by using a chimeric DNA-RNA guide.
Kim H; Lee WJ; Oh Y; Kang SH; Hur JK; Lee H; Song W; Lim KS; Park YH; Song BS; Jin YB; Jun BH; Jung C; Lee DS; Kim SU; Lee SH
Nucleic Acids Res; 2020 Sep; 48(15):8601-8616. PubMed ID: 32687187
[TBL] [Abstract][Full Text] [Related]
15. Efficient gene knockout and genetic interaction screening using the in4mer CRISPR/Cas12a multiplex knockout platform.
Esmaeili Anvar N; Lin C; Ma X; Wilson LL; Steger R; Sangree AK; Colic M; Wang SH; Doench JG; Hart T
Nat Commun; 2024 Apr; 15(1):3577. PubMed ID: 38678031
[TBL] [Abstract][Full Text] [Related]
16. Editor's cut: DNA cleavage by CRISPR RNA-guided nucleases Cas9 and Cas12a.
Swartjes T; Staals RHJ; van der Oost J
Biochem Soc Trans; 2020 Feb; 48(1):207-219. PubMed ID: 31872209
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas12a has widespread off-target and dsDNA-nicking effects.
Murugan K; Seetharam AS; Severin AJ; Sashital DG
J Biol Chem; 2020 Apr; 295(17):5538-5553. PubMed ID: 32161115
[TBL] [Abstract][Full Text] [Related]
18. Gene Disruption Using Chemically Modified CRISPR-Cpf1 RNA.
McMahon MA; Rahdar M
Methods Mol Biol; 2021; 2162():49-60. PubMed ID: 32926377
[TBL] [Abstract][Full Text] [Related]
19. Lb2Cas12a and its engineered variants mediate genome editing in human cells.
Liu X; Lin L; Tang L; Xie H; Gu L; Lv X; Liu C; Zhao J; Deng R; Liu Y; Qu J; Gu F
FASEB J; 2021 Apr; 35(4):e21270. PubMed ID: 33715215
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas12a System for Biosensing and Gene Regulation.
Shi Y; Fu X; Yin Y; Peng F; Yin X; Ke G; Zhang X
Chem Asian J; 2021 Apr; 16(8):857-867. PubMed ID: 33638271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
